Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS.

Abstract:

:Recent population-based studies demonstrate an increased fracture risk with monoclonal gammopathy of undetermined significance (MGUS). The etiology of this increased risk remains unclear, however, because areal bone mineral density (aBMD) measurements by dual-energy x-ray absorptiometry cannot assess bone microstructural properties critical to determining bone quality and strength. To better define the skeletal effects of MGUS, we performed aBMD and high-resolution peripheral quantitative computed tomography volumetric bone mineral density (vBMD) measurements in 50 MGUS patients (20 females, 30 males; mean ± SEM age, 70.5 ± 1.4 years) and 100 matched control subjects. Relative to controls, MGUS patients had decreased aBMD at the femoral neck (P = .05) and total femur (P < .05) but no differences at other sites. In contrast, high-resolution peripheral quantitative computed tomography showed markedly diminished cortical thickness (P < .05) and increased endocortical area (P < .01). Average vBMD (P < .01), cortical vBMD (P < .001), and trabecular thickness (P < .01) were all significantly decreased in MGUS patients, suggestive of impaired bone formation. Serum levels of the Wnt pathway inhibitor Dickkopf-related protein 1 (P < .001) and osteoclast-activating factor MIP-1α (P < .05) also were significantly elevated in MGUS patients. Our data provide the first evidence of altered bone microstructure in MGUS and suggest that cytokines elevated in osteolytic myeloma also may be associated with bone loss in MGUS.

journal_name

Blood

journal_title

Blood

authors

Ng AC,Khosla S,Charatcharoenwitthaya N,Kumar SK,Achenbach SJ,Holets MF,McCready LK,Melton LJ 3rd,Kyle RA,Rajkumar SV,Drake MT

doi

10.1182/blood-2011-04-351437

subject

Has Abstract

pub_date

2011-12-15 00:00:00

pages

6529-34

issue

25

eissn

0006-4971

issn

1528-0020

pii

blood-2011-04-351437

journal_volume

118

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia.

    abstract::We administered gemtuzumab ozogamycin ("mylotarg"; 9 mg/m(2) day 1 or 5) and all-trans retinoic acid (ATRA) to 19 patients with untreated acute promyelocytic leukemia (APL). There were 3 patients who also received idarubicin because of a white blood cell (WBC) count of more than 30 000/microL. In complete remission (C...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2001-12-0174

    authors: Estey EH,Giles FJ,Beran M,O'Brien S,Pierce SA,Faderl SH,Cortes JE,Kantarjian HM

    更新日期:2002-06-01 00:00:00

  • The morphological and biochemical characterization of a line of rat promegakaryoblasts.

    abstract::Biochemical and morphological evidence is presented to support the characterization of a rat bone-marrow-derived cell line (RPM) as an analog of the promegakaryoblast. The conditions for in vitro growth and maturation of the RPM line are described. Rapid proliferation of the RPM line is readily achieved when cultures ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Weinstein R,Stemerman MB,MacIntyre DE,Steinberg HN,Maciag T

    更新日期:1981-07-01 00:00:00

  • Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation.

    abstract::Myeloproliferative neoplasms (MPNs) are a group of blood cancers that arise following the sequential acquisition of genetic lesions in hematopoietic stem and progenitor cells (HSPCs). We identify mutational cooperation between Jak2V617F expression and Dnmt3a loss that drives progression from early-stage polycythemia v...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-04-846220

    authors: Jacquelin S,Straube J,Cooper L,Vu T,Song A,Bywater M,Baxter E,Heidecker M,Wackrow B,Porter A,Ling V,Green J,Austin R,Kazakoff S,Waddell N,Hesson LB,Pimanda JE,Stegelmann F,Bullinger L,Döhner K,Rampal RK,Heckl D

    更新日期:2018-12-27 00:00:00

  • Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia.

    abstract::The 8p11 myeloproliferative syndrome (EMS) is associated with translocations that disrupt the FGFR1 gene. To date, 8 fusion partners of FGFR1 have been identified. However, no primary leukemia cell lines were identified that contain any of these fusions. Here, we screened more than 40 acute myeloid leukemia cell lines...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-06-026666

    authors: Gu TL,Goss VL,Reeves C,Popova L,Nardone J,Macneill J,Walters DK,Wang Y,Rush J,Comb MJ,Druker BJ,Polakiewicz RD

    更新日期:2006-12-15 00:00:00

  • Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery.

    abstract::Adenovirus infections occur in 5% to 21% of patients following stem cell transplantation (SCT), with an associated mortality of up to 50%. However, a lack of prospective studies has hampered further developments in the understanding and management of this infection in the posttransplantation setting. We prospectively ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-02-0377

    authors: Chakrabarti S,Mautner V,Osman H,Collingham KE,Fegan CD,Klapper PE,Moss PA,Milligan DW

    更新日期:2002-09-01 00:00:00

  • JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities.

    abstract::Ras-associated autoimmune leukoproliferative disorder (RALD) is a chronic, nonmalignant condition that presents with persistent monocytosis and is often associated with leukocytosis, lymphoproliferation, and autoimmune phenomena. RALD has clinical and laboratory features that overlap with those of juvenile myelomonocy...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-11-567917

    authors: Calvo KR,Price S,Braylan RC,Oliveira JB,Lenardo M,Fleisher TA,Rao VK

    更新日期:2015-04-30 00:00:00

  • Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996).

    abstract::Three new human myeloma cell lines (U-1957, U-1958, and U-1996) have been established in vitro. The cell lines are Epstein-Barr virus (EBV) negative, monoclonal, and aneuploid and should thus represent malignant cell populations and not EBV-carrying non-neoplastic B lymphoblastoid cell lines. The myeloma origin of the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jernberg H,Nilsson K,Zech L,Lutz D,Nowotny H,Scheirer W

    更新日期:1987-06-01 00:00:00

  • Thalidomide as salvage therapy for chronic graft-versus-host disease.

    abstract::Thalidomide has been reported to be an effective agent for treatment of chronic graft-versus-host disease (CGVHD). To determine the efficacy of this agent in patients with refractory CGVHD a total of 80 patients who failed to respond to prednisone (PSE) or PSE and cyclosporine (CSA) were treated with thalidomide. Sixt...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Parker PM,Chao N,Nademanee A,O'Donnell MR,Schmidt GM,Snyder DS,Stein AS,Smith EP,Molina A,Stepan DE,Kashyap A,Planas I,Spielberger R,Somlo G,Margolin K,Zwingenberger K,Wilsman K,Negrin RS,Long GD,Niland JC,Blume K

    更新日期:1995-11-01 00:00:00

  • Regulatory T-cell compartmentalization and trafficking.

    abstract::CD4(+)CD25(+)FOXP3(+) regulatory T cells (CD4(+) Treg cells) are thought to differentiate in the thymus and immigrate from the thymus to the periphery. Treg cells can regulate both acquired and innate immunity through multiple modes of suppression. The cross-talk between Treg cells and targeted cells, such as antigen-...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2006-01-0177

    authors: Wei S,Kryczek I,Zou W

    更新日期:2006-07-15 00:00:00

  • Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.

    abstract::Peripheral blood mononuclear cells (PBMC) from 17 patients receiving HLA-identical sibling bone marrow grafts were stimulated with host pretransplant PBMC. Cytotoxic T-cell lines (TCL) with specificity for host pretransplant PBMC were obtained from 9 of these patients, all presenting with severe graft-versus-host dise...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Niederwieser D,Grassegger A,Auböck J,Herold M,Nachbaur D,Rosenmayr A,Gächter A,Nussbaumer W,Gaggl S,Ritter M

    更新日期:1993-04-15 00:00:00

  • Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment.

    abstract::In ischemic stroke, treatment options are limited. Therapeutic thrombolysis is restricted to the first few hours after stroke, and the utility of current platelet aggregation inhibitors, including GPIIb/IIIa receptor antagonists, and anticoagulants is counterbalanced by the risk of intracerebral bleeding complications...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2008-04-144758

    authors: Stoll G,Kleinschnitz C,Nieswandt B

    更新日期:2008-11-01 00:00:00

  • Serial studies in von Willebrand's disease: variability versus "variants".

    abstract::The variability of laboratory findings in von Willebrand's disease (vWd) was evaluated by performing serial studies of bleeding time (BT), factor VIII coagulant activity (VIII:C), factor-VIII-related antigen (VIIIR:Ag) and ristocetin cofactor (VIIIR:Rcof) in 50 individuals from 25 families with this disorder. The type...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Abildgaard CF,Suzuki Z,Harrison J,Jefcoat K,Zimmerman TS

    更新日期:1980-10-01 00:00:00

  • Hepatosplenic candidiasis--a contraindication to marrow transplantation?

    abstract::To determine whether a prior history of hepatosplenic candidiasis resulted in increased Candida-associated morbidity and mortality after marrow transplant, 15 consecutive patients with biopsy-proven hepatosplenic candidiasis were observed prospectively. All patients received amphotericin B before transplant. Amphoteri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bjerke JW,Meyers JD,Bowden RA

    更新日期:1994-10-15 00:00:00

  • Hematopoietic progenitor kinase 1 (HPK1) is required for LFA-1-mediated neutrophil recruitment during the acute inflammatory response.

    abstract::Recruitment of polymorphonuclear neutrophils (PMNs) to sites of acute inflammation critically depends on β2 integrins (CD11/CD18). Recently, the mammalian actin-binding protein 1 (mAbp1) was identified as an important adaptor protein regulating PMN trafficking downstream of β2 integrins. Here, we show that mAbp1 const...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-08-451385

    authors: Jakob SM,Pick R,Brechtefeld D,Nussbaum C,Kiefer F,Sperandio M,Walzog B

    更新日期:2013-05-16 00:00:00

  • Immunologic reconstitution after haploidentical bone marrow transplantation for immune deficiency disorders: treatment of bone marrow cells with monoclonal antibody CT-2 and complement.

    abstract::Patients with congenital T lymphocyte deficiency disorders received transplants with parental bone marrow depleted of mature T cells by the use of an anti-T cell monoclonal antibody (CT-2) and complement. Our results with 16 consecutive patients (20 transplants) showed rapid engraftment of donor cells; cytoreduction (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Moen RC,Horowitz SD,Sondel PM,Borcherding WR,Trigg ME,Billing R,Hong R

    更新日期:1987-09-01 00:00:00

  • The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients.

    abstract::Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, aplastic anemia, and a susceptibility to leukemia. There are at least 8 complementation groups (A through H). Extensive analyses of the FA group C gene FANCC in Western countries revealed that 10% to 15% of FA patients have mu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Futaki M,Yamashita T,Yagasaki H,Toda T,Yabe M,Kato S,Asano S,Nakahata T

    更新日期:2000-02-15 00:00:00

  • CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma.

    abstract::Primary effusion lymphoma (PEL) is an aggressive subtype of non-Hodgkin lymphoma characterized by short survival with current therapies, emphasizing the urgent need to develop new therapeutic approaches. Brentuximab vedotin (SGN-35) is an anti-CD30 monoclonal antibody (cAC10) conjugated by a protease-cleavable linker ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-481713

    authors: Bhatt S,Ashlock BM,Natkunam Y,Sujoy V,Chapman JR,Ramos JC,Mesri EA,Lossos IS

    更新日期:2013-08-15 00:00:00

  • In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1.

    abstract::Transforming growth factor-beta1 (TGF-beta1) has potent physiologic and pathologic effects on a variety of cell types at subnanomolar concentrations. Platelets contain 40 times as much TGF-beta1 as other cells and secrete it as an inactive (latent) form in complex with latency-associated peptide (LAP), which is disulf...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-151753

    authors: Ahamed J,Burg N,Yoshinaga K,Janczak CA,Rifkin DB,Coller BS

    更新日期:2008-11-01 00:00:00

  • Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.

    abstract::Rituximab therapy is associated with a long in vivo persistence, yet little is known about the effect of circulating rituximab on B-cell non-Hodgkin lymphoma (B-NHL) targeting by the other available anti-CD20 monoclonal antibodies (MoAbs) (131)iodine-tositumomab and (90)yttrium-ibritumomab tiuxetan. Therefore we asses...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-132142

    authors: Gopal AK,Press OW,Wilbur SM,Maloney DG,Pagel JM

    更新日期:2008-08-01 00:00:00

  • A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka- platelets lack detectable GPIV (CD36).

    abstract::It has recently been shown that the Naka antigen, which is absent in 3% to 11% of Japanese blood donors, is expressed on platelet glycoprotein IV (GPIV; CD36) (Tomiyama et al, BLOOD, 75:684, 1990). In the present studies, flow cytometry was used to distinguish differences in the reactivity of Naka+ and Naka- platelets...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yamamoto N,Ikeda H,Tandon NN,Herman J,Tomiyama Y,Mitani T,Sekiguchi S,Lipsky R,Kralisz U,Jamieson GA

    更新日期:1990-11-01 00:00:00

  • How I treat disseminated intravascular coagulation.

    abstract::Disseminated intravascular coagulation (DIC) is a condition characterized by systemic activation of coagulation, potentially leading to thrombotic obstruction of small and midsize vessels, thereby contributing to organ dysfunction. At the same time, ongoing consumption of platelets and coagulation proteins results in ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-10-804096

    authors: Levi M,Scully M

    更新日期:2018-02-22 00:00:00

  • Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment.

    abstract::Natural killer (NK) cells play critical roles in protection against hematological malignancies but can acquire a dysfunctional state, which limits antitumor immunity. However, the underlying reasons for this impaired NK cell function remain to be uncovered. We found that NK cells in aggressive B-cell lymphoma underwen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005602

    authors: Kobayashi T,Lam PY,Jiang H,Bednarska K,Gloury R,Murigneux V,Tay J,Jacquelot N,Li R,Tuong ZK,Leggatt GR,Gandhi MK,Hill MM,Belz GT,Ngo S,Kallies A,Mattarollo SR

    更新日期:2020-12-24 00:00:00

  • Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis.

    abstract::Delivery of biologically active peptides into human polymorphonuclear neutrophils (PMNs) has implications for studying cellular functions and may be therapeutically relevant. The transcription factor nuclear factor-kappaB (NF-kappaB) regulates the expression of multiple genes controlling inflammation, proliferation, a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2960

    authors: Choi M,Rolle S,Wellner M,Cardoso MC,Scheidereit C,Luft FC,Kettritz R

    更新日期:2003-09-15 00:00:00

  • Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction.

    abstract::C-C chemokine receptor type 7 (CCR7) is a chemokine receptor playing a pivotal role in the induction of human natural killer (NK)-cell migration to lymph nodes. We show that "licensed" peripheral blood killer immunoglobulin-like receptor-positive (KIR(+)) NK-cell populations, as well as KIR(+) NK-cell clones, de novo ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-222265

    authors: Marcenaro E,Cantoni C,Pesce S,Prato C,Pende D,Agaugué S,Moretta L,Moretta A

    更新日期:2009-11-05 00:00:00

  • Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states.

    abstract::Apoptotic cells were shown to induce dendritic cell immune tolerance. We applied a proteomic approach to identify molecules that are secreted from apoptotic monocytes, and thus may mediate engulfment and immune suppression. Supernatants of monocytes undergoing apoptosis were collected and compared using sodium dodecyl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-03-013334

    authors: Krispin A,Bledi Y,Atallah M,Trahtemberg U,Verbovetski I,Nahari E,Zelig O,Linial M,Mevorach D

    更新日期:2006-11-15 00:00:00

  • Mcl-1 and Bcl-x(L) coordinately regulate megakaryocyte survival.

    abstract::Mature megakaryocytes depend on the function of Bcl-x(L), a member of the Bcl-2 family of prosurvival proteins, to proceed safely through the process of platelet shedding. Despite this, loss of Bcl-x(L) does not prevent the growth and maturation of megakaryocytes, suggesting redundancy with other prosurvival proteins....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-12-398834

    authors: Debrincat MA,Josefsson EC,James C,Henley KJ,Ellis S,Lebois M,Betterman KL,Lane RM,Rogers KL,White MJ,Roberts AW,Harvey NL,Metcalf D,Kile BT

    更新日期:2012-06-14 00:00:00

  • The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells.

    abstract::As a dendritic cell (DC) matures, it becomes more potent as an antigen-presenting cell. This functional change is accompanied by a change in DC immunophenotype. The signal transduction events underlying this process are poorly characterized. In this study, we have investigated the signal transduction pathways involved...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ardeshna KM,Pizzey AR,Devereux S,Khwaja A

    更新日期:2000-08-01 00:00:00

  • Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations.

    abstract::Dasatinib is a BCR-ABL inhibitor with 325-fold higher potency than imatinib against unmutated BCR-ABL in vitro. Imatinib failure is commonly caused by BCR-ABL mutations. Here, dasatinib efficacy was analyzed in patients recruited to phase 2/3 trials with chronic-phase chronic myeloid leukemia with or without BCR-ABL m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-04-214221

    authors: Müller MC,Cortes JE,Kim DW,Druker BJ,Erben P,Pasquini R,Branford S,Hughes TP,Radich JP,Ploughman L,Mukhopadhyay J,Hochhaus A

    更新日期:2009-12-03 00:00:00

  • Ph1-positive, bcr-negative acute leukemias: clustering of breakpoints on chromosome 22 in the 3' end of the BCR gene first intron.

    abstract::About 50% of the Philadelphia-positive acute leukemias undergo molecular rearrangements outside the now classical bcr sequence (or M-BCR-1) rearranged in chronic myeloid leukemia (CML). Most of the breakpoints on chromosome 22 have been shown to be clustered in a 10.8-kb region of the first intron of the BCR gene (cal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chen SJ,Chen Z,Hillion J,Grausz D,Loiseau P,Flandrin G,Berger R

    更新日期:1989-04-01 00:00:00

  • The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis.

    abstract::D assemblies make up half of the von Willebrand factor (VWF), yet are of unknown structure. D1 and D2 in the prodomain and D'D3 in mature VWF at Golgi pH form helical VWF tubules in Weibel Palade bodies and template dimerization of D3 through disulfides to form ultralong VWF concatemers. D'D3 forms the binding site fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-10-876300

    authors: Dong X,Leksa NC,Chhabra ES,Arndt JW,Lu Q,Knockenhauer KE,Peters RT,Springer TA

    更新日期:2019-04-04 00:00:00